Shionogi & Co.,Ltd. (4507) Other
Market cap
¥2.86T
P/E ratio
14.6x
Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 10.7 | 12.8 | 14.3 | 14.8 | 13.5 | 12 | 10.6 | 15 | 11.9 | 11.6 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 6,132 | 6,082 | 6,165 | 6,059 | 5,896 | 5,511 | 5,120 | 5,233 | 5,222 | 5,485 | 5,693 | 5,680 | 4,959 | 4,955 |
| Total payout ratio | - | - | - | 104.3 | 27.4 | 68.1 | 49.2 | 58.4 | 66.5 | 73.9 | 29 | 46.3 | 73.5 | 28.6 |